Signaling mechanisms for oxidized LDL-induced oxidative stress and the upregulation of plasminogen activator inhibitor-I in vascular cells
Author:
Affiliation:
1. Departments of Physiology, University of Manitoba, Canada
2. Diabetes Research Group, Departments of Physiology, University of Manitoba, 835–715 McDermot Ave Winnipeg, Manitoba R3E 3P4, Canada
Publisher
Informa UK Limited
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism
Link
https://www.tandfonline.com/doi/pdf/10.2217/clp.10.6
Reference137 articles.
1. Ross R: Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340(2), 115–126 (1999).
2. ▪ LDL-C is considered as one of the principal risk factors for atherosclerosis. This review explains the pathophysiology of atherosclerosis as an inflammatory disease.
3. Devaraj S, Jialal I: Oxidized low-density lipoprotein and atherosclerosis. Int. J. Clin. Lab. Res. 26(3), 178–184 (1996).
4. Shen GX: Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells. Mol. Cell Biochem. 246(1–2), 69–74 (2003).
5. Jovinge S, Ares MP, Kallin B, Nilsson J: Human monocytes/macrophages release TNF-α in response to ox-LDL. Arterioscler. Thromb. Vasc. Biol. 16 (12), 1573–1579 (1996).
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells;International Journal of Molecular Sciences;2023-03-07
2. Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice;Toxicology and Applied Pharmacology;2020-12
3. The Vascular Consequences of Metabolic Syndrome: Rodent Models, Endothelial Dysfunction, and Current Therapies;Frontiers in Pharmacology;2020-03-04
4. miR‐221‐3p inhibits oxidized low‐density lipoprotein induced oxidative stress and apoptosis via targeting a disintegrin and metalloprotease‐22;Journal of Cellular Biochemistry;2018-10-25
5. An update on serum amyloid A–LDL and its potential use for dyslipidemic patients receiving lipid-modulating treatment;Clinical Lipidology;2013-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3